Back to User profile » Dr Jingwen Zhou
Paper published by Dr Jingwen Zhou:
Original Research
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K
Journal of Hepatocellular Carcinoma 2022, 9:157-170
Published Date: 10 March 2022